Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sixten Harborg

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Discover Oncology|July 1, 2025
Understanding the role of obesity in endocrine therapy for postmenopausal breast cancer: significance of the BIG 1-98 and ATAC trial dataSixten Harborg, Signe Borgquist
Archives of Gynecology and Obstetrics|October 25, 2021
Letter to the editor regarding: "The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis"Sixten Harborg, Thomas P Ahern, Signe Borgquist
Breast Cancer Research and Treatment|July 5, 2019
RE.: Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancerSixten Harborg, Deirdre P Cronin-Fenton, Signe Borgquist
Journal of Internal Medicine|January 8, 2025
Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta-analysisSixten Harborg, Helene Borup Larsen, Stine Elsgaard, et al.
Breast (Edinburgh, Scotland)|January 7, 2022
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer StudyMaria Inasu, Maria Feldt, Helena Jernström, et al.
Lipids in Health and Disease|July 2, 2022
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort studyKasper Aalbæk Kjærgaard, Sixten Harborg, Henrik Kjærulf Jensen, et al.
Breast Cancer Research and Treatment|June 24, 2020
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort studySixten Harborg, Uffe Heide-Jørgensen, Thomas P Ahern, et al.
NPJ Breast Cancer|September 11, 2021
Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysisSixten Harborg, Robert Zachariae, Julia Olsen, et al.
JAMA Network Open|October 30, 2025
Postdiagnosis Statin Use and Breast Cancer MortalitySixten Harborg, Lars Pedersen, Henrik T Sørensen, et al.
JAMA Network Open|October 13, 2023
Obesity and Risk of Recurrence in Patients With Breast Cancer Treated With Aromatase InhibitorsSixten Harborg, Deirdre Cronin-Fenton, Maj-Britt Raaby Jensen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Discover Oncology|July 1, 2025
Understanding the role of obesity in endocrine therapy for postmenopausal breast cancer: significance of the BIG 1-98 and ATAC trial dataSixten Harborg, Signe Borgquist
Archives of Gynecology and Obstetrics|October 25, 2021
Letter to the editor regarding: "The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis"Sixten Harborg, Thomas P Ahern, Signe Borgquist
Breast Cancer Research and Treatment|July 5, 2019
RE.: Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancerSixten Harborg, Deirdre P Cronin-Fenton, Signe Borgquist
Journal of Internal Medicine|January 8, 2025
Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta-analysisSixten Harborg, Helene Borup Larsen, Stine Elsgaard, et al.
Breast (Edinburgh, Scotland)|January 7, 2022
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer StudyMaria Inasu, Maria Feldt, Helena Jernström, et al.
Lipids in Health and Disease|July 2, 2022
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort studyKasper Aalbæk Kjærgaard, Sixten Harborg, Henrik Kjærulf Jensen, et al.
Breast Cancer Research and Treatment|June 24, 2020
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort studySixten Harborg, Uffe Heide-Jørgensen, Thomas P Ahern, et al.
NPJ Breast Cancer|September 11, 2021
Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysisSixten Harborg, Robert Zachariae, Julia Olsen, et al.
JAMA Network Open|October 30, 2025
Postdiagnosis Statin Use and Breast Cancer MortalitySixten Harborg, Lars Pedersen, Henrik T Sørensen, et al.
JAMA Network Open|October 13, 2023
Obesity and Risk of Recurrence in Patients With Breast Cancer Treated With Aromatase InhibitorsSixten Harborg, Deirdre Cronin-Fenton, Maj-Britt Raaby Jensen, et al.
Pageof 2